Found 5 matching trials
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
PHASE2This study is being done to answer the following question: Can testing brea...
Location
Arthur J.E. Child Comprehensive Cancer Centre
Study of RP-3500, Camonsertib, in Advanced Solid Tumors
PHASE1The primary purpose of this study is to define the maximum tolerated dose (...
Location
#1014, Northwestern University
Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors
PHASE1The primary purpose of this study is to assess the safety and tolerability ...
Location
Participating Site #1018
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
PHASE1This phase I trial tests the safety, side effects, and best dose of camonse...
Location
UPMC Hillman Cancer Center
RP-6306 in Patients With Advanced Cancer
PHASE2This study is being done to answer the following questions:
* Is the new d...